Kevin Neil Johnson, PT,ATC | |
9913 214th St W Ste B, Lakeville, MN 55044-1914 | |
(952) 985-2020 | |
Not Available |
Full Name | Kevin Neil Johnson |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
Location | 9913 214th St W Ste B, Lakeville, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770806374 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 4901 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kevin Neil Johnson, PT,ATC 9913 214th St W Ste B, Lakeville, MN 55044-1914 Ph: (952) 985-2020 | Kevin Neil Johnson, PT,ATC 9913 214th St W Ste B, Lakeville, MN 55044-1914 Ph: (952) 985-2020 |
News Archive
National emergency room data analysis has shown that number of injuries related to cell phones has risen in the last 20 years.
Despite grim prognoses and aggressive treatments, cancer patients suffering from malignant gliomas - primary brain tumors - often rate their quality of life more optimistically than their caregivers do, according to a new Northwestern University Feinberg School of Medicine study.
InnaVirVax, a biopharmaceutical company specialized in research and development on therapeutic and diagnostic solutions for diseases linked to immune dysregulation, today announces the recommendation of its independent Data Safety and Monitoring Board (DSMB) to pursue the Phase 2 study (IPROTECT1) of VAC-3S according to the planned protocol.
Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.
Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.35 million federal grant to study how emulsifiers affect bacteria in the intestinal tract and cause chronic inflammatory diseases in the gut.
› Verified 8 days ago